| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2023-02-08 | 2023-03-21 | 183870 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-24 | 2017-12-18 | 4234 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2018-07-13 | 2018-09-19 | 55738 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-20 | 2020-06-10 | 7420 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-20 | 2020-06-10 | 7411 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-20 | 2018-05-05 | 7402 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-04 | 2017-12-18 | 5495 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-04 | 2017-12-18 | 5492 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-04-04 | 2017-12-18 | 5489 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269831 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269837 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269840 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269826 |
| ATIVAN | 0.5MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269843 |
| ATIVAN | 1MG | TABLET | To be discontinued | 2025-10-17 | 2025-10-17 | 269846 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 |